Key Takeaways
- Volume-led outperformance, margin stability: FY25 revenue reached ₹1,059 crore as the company grew volumes 17%, well above the 7.5% industry rate, while EBITDA margins held firm on the back of a unique cost structure.
- Backward integration is the moat: A proprietary rock phosphate beneficiation plant and 100% captive phosphoric acid give the company a structural cost edge that peers cannot replicate, insulating margins from raw material swings.
- Two large CAPEX bets are now funded and timed: A ₹100 crore sulphuric acid expansion lands by March 2026, and the Dhule greenfield (₹400+ crore turnover potential) is committed for October 2026, with or without the QIP.
- Subsidy is a pass-through, not a profit driver: Management was explicit that the government’s formula compensates for input costs, not margins, and pushed back on the idea that recent concession increases mechanically lift profitability.
- What to watch next quarter: Whether the QIP closes as hoped, any early signal on the phosphoric acid plant’s margin benefit, and the pace of SSP capacity utilization toward the 79% already achieved in Q4.
Volume & Revenue Performance
- SSP drove the beat: Q4 SSP sales volumes jumped 21.2% YoY to 39,723 MT, lifting capacity utilization to 79% from 65% a year ago. The full-year SSP story was one of strong demand traction and better asset turns.
- NPK/DAP stabilized on a larger base: Q4 NPK/DAP volumes surged 42.3% YoY to 36,909 MT. For the full year, sales rose 22% to 1,56,346 MT and utilization improved from 53% to 64%, suggesting the expanded capacity is now absorbing fixed costs more efficiently.
- Industry context: Phosphatic fertilizer industry volumes (ex-MOP) grew 7.5% in FY25, so the company’s 17% volume growth represents consistent share gains, not just a rising tide.
The Cost Moat: Why Margins Hold
- Rock phosphate beneficiation is the differentiator: The company uses locally sourced low-grade rock phosphate and upgrades it in-house, a capability management says no other Indian manufacturer possesses. This significantly lowers SSP production cost and creates a persistent edge over competitors.
- 100% backward integration in phosphoric acid: All phosphoric acid is manufactured captively, eliminating a major variable-cost exposure that peers must manage through purchases. Combined with low CAPEX and low OPEX operations, this structure supports above-peer EBITDA margins.
- Raw material picture is mixed, not alarming: Sulfur prices doubled YoY on volatile global demand, but ammonia and phosphate prices are softer and stable. The government increased price concessions for Kharif 2025 to absorb the sulfur impact, consistent with the pass-through mechanism.
- Working capital is self-correcting with volume: The cash conversion cycle improved because raw material and finished goods holdings stayed flat in absolute terms while throughput rose, so higher utilization mechanically shortens the cycle.
Ostwal: "If you look at our results, you'll see that compared to other companies, we've performed better. One key reason for that is we have a rock phosphate beneficiation plant. So, at any point in time, we have that edge over other manufacturers - because in India, there are no other rock phosphate beneficiation manufacturers."
Subsidy Mechanics: Pass-Through, Not Profit
- The formula, not a windfall: Management described subsidy as price compensation: when input costs rise, the government increases the subsidy to keep the total realization (selling price plus subsidy) covering cost of goods sold plus a reasonable profit. It takes a pan-India view, not a company-specific one.
- No mechanical margin lift from higher concessions: Pressed on whether a subsidy increase flows 1:1 to profitability, management answered that subsidy is not profit and that cost structures and efficiency determine the outcome. The relationship was not quantified, and the answer stayed at the level of principle.
- Stable margin commitment: Despite the sulfur headwind and subsidy adjustments, management expects EBITDA margins to remain similar or improve slightly as production volumes increase and the expanded phosphoric acid plant contributes.
CAPEX: Two Expansions, One Timeline
- Sulphuric acid at Sagar: A 1,65,000-ton capacity addition is underway with a ₹100 crore outlay and a March 2026 operational target. This deepens backward integration further and reduces exposure to purchased sulphuric acid.
- Dhule greenfield: A 3,30,000-ton DAP/NPK plant with captive phosphoric and sulphuric acid is slated to commission by October 2026. Management expects ~40% utilization in the partial first year, adding roughly ₹400 crore in turnover, with full-year contribution in FY27-28.
- Funding is de-risked: The QIP is underway and hoped to close in Q1 FY26, but management was categorical that internal accruals are adequate to fund the expansion on schedule even if the QIP does not materialize.
Gupta: "But in any case, even if QIP does not take place, the company has internal accruals adequate to take care of the expansion. So, expansion will be on the line on the date September 26th we will be on stream whether QIP comes or does not come."
Product & Capacity Updates
- New product launches: The company announced or relaunched Annadata Urea SSP (urea-SSP combination), Annadata Super 6 (enriched with zinc, boron, magnesium), and Annadata Zibo (fortified with zinc and boron), broadening the portfolio beyond plain SSP and NPK.
- Phosphoric acid capacity expanded: Capacity at Sagar reached 69,000 metric tons in March 2025, with the cost-efficiency benefit to flow into the FY26 bottom line.
- Debottlenecking is continuous: Management flagged an ongoing effort to incrementally increase capacities at existing facilities, suggesting volume growth can come from both new assets and better utilization of old ones.
- Trading is opportunistic, not structural: The group imports rock phosphate in shiploads for economies of scale and allocates to group companies at arm’s length. It also imports MOP for direct sale since the government opened the trade to private players last year, but this remains a limited activity.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 15% growth with better profitability | FY26 |
| EBITDA margin | Maintain or slightly improve from current levels | FY26 |
| Sulphuric acid expansion | 1,65,000 tons capacity operational | March 2026 |
| Dhule greenfield plant | Commissioning; ~₹400 crore turnover at 40% utilization in partial year | October 2026 |
| Dhule plant full-year contribution | Full-year operations | FY27-28 |
| QIP closure | Hoped to achieve targets | Q1 FY26 |
| Expansion funding | On stream on schedule via internal accruals even without QIP | September 2026 |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Revenue | ₹297 crore, 103.7% YoY growth and 4.6% sequential increase |
| EBITDA | ₹36 crore, 155.3% YoY growth, margin 12.1% |
| Profit After Tax | ₹14 crore, 984.6% YoY growth, PAT margin 4.8% |
| EBITDA per ton | ₹4,698 |
| Revenue (full year FY25) | ₹1,059 crore, 29.7% YoY growth vs ₹817 crore in FY24 |
| EBITDA (full year FY25) | ₹146 crore, 51.4% YoY growth, margin 13.7% |
| PAT (full year FY25) | ₹57 crore, 132% YoY increase, PAT margin 5.4% |
| EBITDA per ton (full year FY25) | ₹4,287 |
| Revenue growth guidance (FY26) | 15% |
| SSP sales volume | 39,723 metric tons, 21.2% YoY growth |
| SSP capacity utilization | 79%, up from 65% in same period last year |
| NPK/DAP sales volume | 36,909 metric tons, 42.3% YoY growth |
| SSP sales volume (full year FY25) | 1,83,028 metric tons, 12% YoY increase |
| NPK sales volume (full year FY25) | 1,56,346 metric tons, 22% YoY increase |
| NPK/DAP capacity utilization (full year FY25) | 64%, up from 53% in FY24 |
| Outstanding subsidy receivables | ~₹127 crore as of 31st March 2025, vs ₹77 crore on 31st Dec 2024 and ₹106 crore on 31st March 2024 |
| Net debt | ₹307 crore as of 31st March 2025, vs ₹278 crore as on 31st March 2024 |
| SSP market share (Madhya Pradesh) | 9% |
| SSP market share (Chhattisgarh) | 19% |
| Phosphoric acid capacity (post-expansion) | 69,000 metric tons, expanded at Sagar, MP in March 2025 |
| Dhule plant capacity (under construction) | 3,30,000 tons of DAP/NPK, commissioning by October 2026 |
| Dhule plant total capex | ₹550 crore, with ₹202 crore term loan sanctioned for first phase of ₹350 crore |
| Sulphuric acid capacity expansion | 1,65,000 tons additional at Sagar, MP, capex of ₹100 crore, operational by March 2026 |
| FY27 expected turnover addition from Dhule plant | ~₹400 crore at 40% capacity utilization |
| FY27-28 expected turnover addition from Dhule plant | >₹800 crore at 60% capacity utilization |
| Peak incremental revenue from Dhule plant | approximately ₹1,000 crore |
| Price concession increase for SSP (Kharif 2025) | ~42% over previous cycle |
| Price concession increase for NPK (Kharif 2025) | 18% over previous cycle |